<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Biomedical Journal</title>
<title_fa>مجله بیومدیکال ایران</title_fa>
<short_title>IBJ</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ibj.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1028-852X</journal_id_issn>
<journal_id_issn_online>2008-823X</journal_id_issn_online>
<journal_id_pii>-</journal_id_pii>
<journal_id_doi>10.61882/ibj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>-</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>-</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>25</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Recombinant Production of a Novel Fusion Protein: Listeriolysin O Fragment Fused to S1 Subunit Of Pertussis Toxin</title>
	<subject_fa>Molecular Immunology &amp; Vaccines</subject_fa>
	<subject>Molecular Immunology &amp; Vaccines</subject>
	<content_type_fa>مقاله کامل</content_type_fa>
	<content_type>Full Length/Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background:&lt;/strong&gt; Some resources have suggested that genetically inactivated pertussis toxoid (PTs) bear a more protective effect than chemically inactivated products. This study aimed to produce new version of PT, by cloning an inactive pertussis toxin S1 subunit (PTS1) in a fusion form with N-terminal half of the listeriolysin O (LLO) pore-forming toxin. &lt;strong&gt;Methods:&lt;/strong&gt; Deposited pdb structure file of the PT was used to model an extra disulfide bond. Codon-optimized ORF of the PTS1 was used to make recombinant constructs of PTS1 and LLO-PTS1 in the pPSG-IBA35 vector. The recombinant PTS1 and LLO-PTS1 proteins were expressed in &lt;em&gt;BL21 DE3&lt;/em&gt; and &lt;em&gt;SHuffle T7&lt;/em&gt; strains of &lt;em&gt;E. coli&lt;/em&gt; and purified by affinity chromatography. Cytotoxic effects of the recombinant proteins were examined in the MCF-7 cell line. &lt;strong&gt;Results:&lt;/strong&gt; The purity of the products proved to be more than 85%, and the efficiency of the disulfide bond formation in &lt;em&gt;SHuffle T7&lt;/em&gt; strain was higher than &lt;em&gt;BL21 DE3&lt;/em&gt; strain. No cytotoxicity of the recombinant proteins was observed in MCF-7 cells. Soluble recombinant PTS1 and LLO-PTS1 proteins were produced in &lt;em&gt;SHuffle T7&lt;/em&gt; strain of &lt;em&gt;E. coli &lt;/em&gt;with high efficiency of disulfide bonds formation. &lt;strong&gt;Conclusion:&lt;/strong&gt; The LLO-PTS1 with corrected disulfide bonds was successfully expressed in &lt;em&gt;E. coli&lt;/em&gt; S&lt;em&gt;Huffle&lt;/em&gt; &lt;em&gt;T7&lt;/em&gt; strain. Due to the safety for human cells, this chimeric molecule can be an option to prevent pertussis disease if its immunostimulatory effects would be confirmed in the future.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Adjuvant, Cloning, Fusion protein, Pertussis toxin</keyword>
	<start_page>33</start_page>
	<end_page>40</end_page>
	<web_url>http://ibj.pasteur.ac.ir/browse.php?a_code=A-10-1-832&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Hossein </first_name>
	<middle_name></middle_name>
	<last_name>Forghani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0002-3268-0878</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University  of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahin</first_name>
	<middle_name></middle_name>
	<last_name>Jamshidi Makiani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0001-9685-0920</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University  of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hossein </first_name>
	<middle_name></middle_name>
	<last_name>Zarei Jaliani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0002-6324-3785</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Medical Biotechnology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mina </first_name>
	<middle_name></middle_name>
	<last_name>Boustanshenas</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0002-5447-9403</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University  of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Mohsen </first_name>
	<middle_name></middle_name>
	<last_name>Zahraei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0002-1940-2216</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Infectious Disease Center for Communicable Disease Control, Ministry of Health and Medical Education, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
